NOV.DE vs. TM2.F
Compare and contrast key facts about Novo Nordisk A/S (NOV.DE) and Sydbank A/S (TM2.F).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NOV.DE or TM2.F.
Key characteristics
| NOV.DE | TM2.F | |
|---|---|---|
| YTD Return | 16.14% | 188.52% |
| 1Y Return | 16.30% | 180.69% |
| 3Y Return (Ann) | 38.93% | 110.09% |
| 5Y Return (Ann) | 47.39% | 89.43% |
| 10Y Return (Ann) | 42.86% | 59.97% |
| Sharpe Ratio | 0.65 | 1.50 |
| Sortino Ratio | 1.14 | 8.86 |
| Omega Ratio | 1.14 | 2.06 |
| Calmar Ratio | 0.76 | 9.94 |
| Martin Ratio | 2.03 | 26.70 |
| Ulcer Index | 9.91% | 6.74% |
| Daily Std Dev | 30.95% | 119.05% |
| Max Drawdown | -50.94% | -76.16% |
| Current Drawdown | -25.30% | -7.92% |
Fundamentals
| NOV.DE | TM2.F | |
|---|---|---|
| Market Cap | €446.19B | €2.41B |
| EPS | €2.85 | €8.11 |
| PE Ratio | 35.16 | 5.73 |
| PEG Ratio | 1.59 | 0.00 |
| Total Revenue (TTM) | €85.63B | €7.64B |
Correlation
The correlation between NOV.DE and TM2.F is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NOV.DE vs. TM2.F - Performance Comparison
In the year-to-date period, NOV.DE achieves a 16.14% return, which is significantly lower than TM2.F's 188.52% return. Over the past 10 years, NOV.DE has underperformed TM2.F with an annualized return of 42.86%, while TM2.F has yielded a comparatively higher 59.97% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NOV.DE vs. TM2.F - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NOV.DE) and Sydbank A/S (TM2.F). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NOV.DE vs. TM2.F - Dividend Comparison
NOV.DE's dividend yield for the trailing twelve months is around 1.32%, less than TM2.F's 8.81% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NOV.DE Novo Nordisk A/S | 1.32% | 1.01% | 1.18% | 1.27% | 1.99% | 2.09% | 5.96% | 2.28% | 3.69% | 1.25% | 1.69% | 1.82% |
TM2.F Sydbank A/S | 8.81% | 5.81% | 4.09% | 4.74% | 7.14% | 6.84% | 7.52% | 4.25% | 1.48% | 3.21% | 0.00% | 0.00% |
Drawdowns
NOV.DE vs. TM2.F - Drawdown Comparison
The maximum NOV.DE drawdown since its inception was -50.94%, smaller than the maximum TM2.F drawdown of -76.16%. Use the drawdown chart below to compare losses from any high point for NOV.DE and TM2.F. For additional features, visit the drawdowns tool.
Volatility
NOV.DE vs. TM2.F - Volatility Comparison
The current volatility for Novo Nordisk A/S (NOV.DE) is 5.49%, while Sydbank A/S (TM2.F) has a volatility of 9.12%. This indicates that NOV.DE experiences smaller price fluctuations and is considered to be less risky than TM2.F based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NOV.DE vs. TM2.F - Financials Comparison
This section allows you to compare key financial metrics between Novo Nordisk A/S and Sydbank A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities